234 related articles for article (PubMed ID: 24300434)
1. Polyunsaturated fatty acid associations with dopaminergic indices in major depressive disorder.
Sublette ME; Galfalvy HC; Hibbeln JR; Keilp JG; Malone KM; Oquendo MA; Mann JJ
Int J Neuropsychopharmacol; 2014 Mar; 17(3):383-91. PubMed ID: 24300434
[TBL] [Abstract][Full Text] [Related]
2. Omega-3 polyunsaturated fatty acid (PUFA) status in major depressive disorder with comorbid anxiety disorders.
Liu JJ; Galfalvy HC; Cooper TB; Oquendo MA; Grunebaum MF; Mann JJ; Sublette ME
J Clin Psychiatry; 2013 Jul; 74(7):732-8. PubMed ID: 23945451
[TBL] [Abstract][Full Text] [Related]
3. Treatment enhances ultradian rhythms of CSF monoamine metabolites in patients with major depressive episodes.
Salomon RM; Kennedy JS; Johnson BW; Urbano Blackford J; Schmidt DE; Kwentus J; Gwirtsman HE; Gouda JF; Shiavi RG
Neuropsychopharmacology; 2005 Nov; 30(11):2082-91. PubMed ID: 15856079
[TBL] [Abstract][Full Text] [Related]
4. Relationships of Cerebrospinal Fluid Monoamine Metabolite Levels With Clinical Variables in Major Depressive Disorder.
Yoon HS; Hattori K; Ogawa S; Sasayama D; Ota M; Teraishi T; Kunugi H
J Clin Psychiatry; 2017; 78(8):e947-e956. PubMed ID: 28749090
[TBL] [Abstract][Full Text] [Related]
5. Low omega-3 polyunsaturated fatty acids predict reduced response to standard antidepressants in patients with major depressive disorder.
Cussotto S; Delgado I; Oriolo G; Kemper J; Begarie D; Dexpert S; Sauvant J; Leboyer M; Aouizerate B; Martin-Santos R; Schaefer M; Capuron L
Depress Anxiety; 2022 May; 39(5):407-418. PubMed ID: 35357051
[TBL] [Abstract][Full Text] [Related]
6. Cerebrospinal fluid monoamine metabolite concentrations in depressive disorder: A meta-analysis of historic evidence.
Ogawa S; Tsuchimine S; Kunugi H
J Psychiatr Res; 2018 Oct; 105():137-146. PubMed ID: 30219563
[TBL] [Abstract][Full Text] [Related]
7. Essential fatty acids predict metabolites of serotonin and dopamine in cerebrospinal fluid among healthy control subjects, and early- and late-onset alcoholics.
Hibbeln JR; Linnoila M; Umhau JC; Rawlings R; George DT; Salem N
Biol Psychiatry; 1998 Aug; 44(4):235-42. PubMed ID: 9715354
[TBL] [Abstract][Full Text] [Related]
8. Omega-3 polyunsaturated fatty acids (n-3 PUFAs), somatic and fatigue symptoms in cardiovascular diseases comorbid major depressive disorder (MDD): A randomized controlled trial.
Chang JP; Chang SS; Chen HT; Chien YC; Yang HT; Huang SY; Tseng PT; Chang CH; Galecki P; Su KP
Brain Behav Immun; 2023 Aug; 112():125-131. PubMed ID: 37301235
[TBL] [Abstract][Full Text] [Related]
9. Stereoselective metabolism of citalopram in plasma and cerebrospinal fluid of depressive patients: relationship with 5-HIAA in CSF and clinical response.
Nikisch G; Mathé AA; Czernik A; Eap CB; Jiménez-Vasquez P; Brawand-Amey M; Baumann P
J Clin Psychopharmacol; 2004 Jun; 24(3):283-90. PubMed ID: 15118482
[TBL] [Abstract][Full Text] [Related]
10. Low plasma eicosapentaenoic acid levels are associated with elevated trait aggression and impulsivity in major depressive disorder with a history of comorbid substance use disorder.
Beier AM; Lauritzen L; Galfalvy HC; Cooper TB; Oquendo MA; Grunebaum MF; Mann JJ; Sublette ME
J Psychiatr Res; 2014 Oct; 57():133-40. PubMed ID: 25017608
[TBL] [Abstract][Full Text] [Related]
11. Omega-3 polyunsaturated fatty acids in cardiovascular diseases comorbid major depressive disorder - Results from a randomized controlled trial.
Chang JP; Chang SS; Yang HT; Chen HT; Chien YC; Yang B; Su H; Su KP
Brain Behav Immun; 2020 Mar; 85():14-20. PubMed ID: 30902738
[TBL] [Abstract][Full Text] [Related]
12. Plasma Phospholipid Polyunsaturated Fatty Acid Associations with Neurocognition.
Ling J; Keilp JG; Galfalvy HC; Cardino VN; Ahmed A; Burke AK; Fenton JI; Mann JJ; Sublette ME
Nutrients; 2023 Oct; 15(21):. PubMed ID: 37960195
[TBL] [Abstract][Full Text] [Related]
13. Omega-3 polyunsaturated fatty acid supplementation and white matter changes in major depression.
Chhetry BT; Hezghia A; Miller JM; Lee S; Rubin-Falcone H; Cooper TB; Oquendo MA; Mann JJ; Sublette ME
J Psychiatr Res; 2016 Apr; 75():65-74. PubMed ID: 26802812
[TBL] [Abstract][Full Text] [Related]
14. Validation of a food frequency questionnaire to assess intake of n-3 polyunsaturated fatty acids in subjects with and without major depressive disorder.
Sublette ME; Segal-Isaacson CJ; Cooper TB; Fekri S; Vanegas N; Galfalvy HC; Oquendo MA; Mann JJ
J Am Diet Assoc; 2011 Jan; 111(1):117-123.e1-2. PubMed ID: 21185973
[TBL] [Abstract][Full Text] [Related]
15. Disentangling the Molecular Mechanisms of the Antidepressant Activity of Omega-3 Polyunsaturated Fatty Acid: A Comprehensive Review of the Literature.
Kalkman HO; Hersberger M; Walitza S; Berger GE
Int J Mol Sci; 2021 Apr; 22(9):. PubMed ID: 33922396
[TBL] [Abstract][Full Text] [Related]
16. A replication study of violent and nonviolent subjects: cerebrospinal fluid metabolites of serotonin and dopamine are predicted by plasma essential fatty acids.
Hibbeln JR; Umhau JC; Linnoila M; George DT; Ragan PW; Shoaf SE; Vaughan MR; Rawlings R; Salem N
Biol Psychiatry; 1998 Aug; 44(4):243-9. PubMed ID: 9715355
[TBL] [Abstract][Full Text] [Related]
17. CSF amine metabolites and depression.
Peabody CA; Faull KF; King RJ; Whiteford HA; Barchas JD; Berger PA
Psychiatry Res; 1987 May; 21(1):1-7. PubMed ID: 2440071
[TBL] [Abstract][Full Text] [Related]
18. International Society for Nutritional Psychiatry Research Practice Guidelines for Omega-3 Fatty Acids in the Treatment of Major Depressive Disorder.
Guu TW; Mischoulon D; Sarris J; Hibbeln J; McNamara RK; Hamazaki K; Freeman MP; Maes M; Matsuoka YJ; Belmaker RH; Jacka F; Pariante C; Berk M; Marx W; Su KP
Psychother Psychosom; 2019; 88(5):263-273. PubMed ID: 31480057
[TBL] [Abstract][Full Text] [Related]
19. Aggressivity, suicide attempts, and depression: relationship to cerebrospinal fluid monoamine metabolite levels.
Placidi GP; Oquendo MA; Malone KM; Huang YY; Ellis SP; Mann JJ
Biol Psychiatry; 2001 Nov; 50(10):783-91. PubMed ID: 11720697
[TBL] [Abstract][Full Text] [Related]
20. Clomipramine-induced serum prolactin as a marker for serotonin and dopamine turnover: results of an open label study.
Cordes J; Kahl KG; Werner C; Henning U; Regenbrecht G; Larisch R; Schmidt-Kraepelin C; Thünker J; Agelink MW; Löffler S; Hohlfeld T; Gaebel W; Klimke A
Eur Arch Psychiatry Clin Neurosci; 2011 Dec; 261(8):567-73. PubMed ID: 21404115
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
